You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MF

Showing 1 - 25 of 5,757
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Presbyopia Trial in Johns Creek (Lehfilcon A multifocal contact lenses, Lotrafilcon B multifocal contact lenses, Hydrogen

Recruiting
  • Presbyopia
  • Lehfilcon A multifocal contact lenses
  • +2 more
  • Johns Creek, Georgia
    Alcon Study Site 07898
Feb 3, 2023

Presbyopia Trial in Johns Creek (Lehfilcon A multlifocal contact lenses, Lotrafilcon B multifocal contact lenses, Hydrogen

Recruiting
  • Presbyopia
  • Lehfilcon A multlifocal contact lenses
  • +2 more
  • Johns Creek, Georgia
    Johns Creek Research Clinic
Mar 13, 2023

Graves Disease Trial in Göteborg (MF course, Usual health care)

Recruiting
  • Graves Disease
  • MF course
  • Usual health care
  • Göteborg, Sweden
    Agneta Lindo
Nov 17, 2023

Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
Jan 18, 2022

Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)

Recruiting
  • Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
  • chlormethine gel
  • Bordeaux, France
  • +1 more
Aug 17, 2022

Influenza, Human, Infections, Respiratory Tract Infections Trial in Philippines, United States (Low dose A/H2N3c + standard dose

Not yet recruiting
  • Influenza, Human
  • +4 more
  • Low dose A/H2N3c + standard dose MF59
  • +5 more
  • Rockville, Maryland
  • +7 more
May 26, 2023

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Asthma, Airway Inflammation Trial (mometasone furoate/formoterol 100/10 mcg, mometasone furoate/formoterol 200/10 mcg,

Completed
Has Results
  • Asthma
  • Airway Inflammation
  • mometasone furoate/formoterol 100/10 mcg
  • +5 more
  • (no location specified)
Feb 7, 2022

Asthma Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI))

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) combination
  • Mometasone furoate MDI (MF MDI)
  • (no location specified)
Feb 7, 2022

MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Nov 29, 2021

Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)

Active, not recruiting
  • Myelofibrosis
  • Antwerpen, Belgium
  • +11 more
Aug 19, 2022

Early Disease Onset Trial (Puva (psoralin and uva ))

Not yet recruiting
  • Early Disease Onset
  • Puva (psoralin and uva )
  • (no location specified)
Sep 27, 2023

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Presbyopia Trial in United States (Lehfilcon A multifocal contact lenses, Lotrafilcon B multifocal contact lenses, CLEAR CARE®)

Completed
  • Presbyopia
  • Lehfilcon A multifocal contact lenses
  • +2 more
  • Maitland, Florida
  • +7 more
Sep 26, 2022

Asthma Trial (Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI, Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5

Completed
Has Results
  • Asthma
  • Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI
  • Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
  • (no location specified)
Feb 7, 2022

Retinal Disease, Healthy Population Trial in Banha (Multifocal electroretinogram (mf-ERG) by electroretinogram device)

Recruiting
  • Retinal Disease
  • Healthy Population
  • Multifocal electroretinogram (mf-ERG) by electroretinogram device
  • Banhā, Banha, Egypt
    Ahmed Abdelshafy Tabl
Jul 18, 2022

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023